MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202537065626 A) filed by Anaveon Ag, Basel, Switzerland, on July 9, for 'il-2 fusion protein.'
Inventor(s) include Huber, Christoph; Katopodis, Andreas; and Murer, Patrizia.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to PD-1:PD-L1 non-blocking immunoconjugates comprising an IL-2 polypeptide providing a biased signal to the dimeric IL-2 receptor, and a PD-1 targeting domain, and their use for treating cancer."
The patent application was internationally filed on Dec. 21, 2023, under International application No.PCT/EP20...